Drug therapy for patients with systolic heart failure after the PARADIGM-HF trial: in need of a new paradigm of LCZ696 implementation in clinical practice
Crossref DOI link: https://doi.org/10.1186/s12916-015-0272-0
Published Online: 2015-02-18
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Filippatos, Gerasimos
Farmakis, Dimitrios
Parissis, John
Lekakis, John
License valid from 2015-02-18